Navigation Links
Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
Date:3/6/2008

CARLSBAD, Calif., March 6 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a specialized laboratory services provider, today announced the company's participation in the Cowen and Company 28th Annual Health Care Conference at the Boston Marriott Copley Place Hotel in Boston, Mass., March 17 - 20, 2008.

Dr. Tina Nova Bennett, President and CEO of Genoptix, and Sam Riccitelli, COO, will present at the conference on Monday, March 17, 2008 beginning at approximately 1:50pm EDT. They will provide an overview of the company's specialized diagnostic laboratory services business, growth strategies and 2007 financial results.

The presentation is expected to last approximately 30 minutes, followed by a short question and answer session, all of which will be webcast live on the Internet and accessible through the investor relations section of the Genoptix website at http://www.genoptix.com. Listeners should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. A replay will also be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Actual results may differ materially from those projected. Genoptix disclaims, however, any intent or obligations to update these forward-looking statements.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Announces Pricing of Secondary Public Offering
2. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
3. Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007
4. Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
5. Genoptix, Inc. Announces Pricing for Initial Public Offering
6. SXC Health Solutions Announces 2007 Fourth Quarter and Year-end Financial Results
7. The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter Makeover for Mom Contest
8. Mindray Medical International Announces Full Year and Fourth Quarter 2007 Results
9. Trubion Announces Presentations at Upcoming Investor Conferences
10. Martek Announces First Quarter 2008 Financial Results
11. HealthFitness Announces 2007 Fourth Quarter and Full-Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 2017 , ... Award-winning medical group Allied Anesthesia today announced ... chair for Orange County health care system CalOptima Friday. CalOptima announced its election ... Mark Refowitz’s term, which runs through June 30 of this year, until another ...
(Date:3/28/2017)... Appleton, WI (PRWEB) , ... March 28, 2017 ... ... how self-funded health plans work, the Self-Funding Success website has recently developed and ... about Self-Funded Health Plans ” was created based on common inquiries the site’s ...
(Date:3/28/2017)... ... March 28, 2017 , ... Prominant bariatric surgeon ... is thrilled to offer the recently FDA-approved Obalon Balloon System to his patients. ... SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. Dr. Liu is ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/27/2017)... , ... March 27, 2017 , ... New patients who ... for leading sleep apnea treatment, with or without a referral. Sleep apnea is often ... can include daytime sleepiness, morning headaches and chronic snoring. , Dr. Braasch seeks ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company developing immunogene ... Chief Operating Officer, is scheduled to present a corporate overview at ... Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at 3:00 ... ... Future Leaders in Biotech Industry – Friday, April 7, 2017 at ...
(Date:3/24/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 ... of cell therapy manufacturing and focuses both on contract manufacturers ... are anticipated to emerge as viable alternatives to conventional treatment ...
Breaking Medicine Technology: